Financials
- Market Capitalization 3.85 B
- Employee 182
- Founded 2002
- CEO N/A
- Website www.catalystpharma.com
- Headquarter Delaware, United States
- FIGI BBG000GZDC67
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
14.31
ratio cours/chiffre d'affaires
5.28
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1450 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.73 USD | -3.73% | -7.54% | +11.26% | +160.87% | 4.27 B USD | ||
| 1529 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.29 USD | +0.03% | -9.19% | +8.97% | -8.22% | 3.89 B USD | ||
| 1554 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.02 USD | +0.46% | -4.09% | +14.20% | +74.64% | 3.73 B USD | ||
| 1568 | RLAY Relay Therapeutics, Inc. - Common Stock | 19.08 USD | +1.87% | -3.20% | +27.28% | +437.46% | 3.66 B USD |